Edwards Lifesciences designs medical devices that save patients with cardiovascular disease. The company specialises in structural heart innovations including transcatheter heart valves, surgical valve technologies, and implantable heart failure systems. These products treat severe aortic stenosis and mitral disease, offering minimally invasive alternatives to open-heart surgery for critically ill patients. Founded in 1958, Edwards partners with physicians to deliver innovations backed by clinical evidence. With 16,000 employees across 50 locations, it invests 18 per cent of revenue into research. Edwards has impacted one million patients and maintains commitment to advancing cardiovascular medicine through discovery and collaboration.
15800
Team Members
1958
Founded
Medical Devices
Sector
Hybrid
Work Environment
A world where every patient with structural heart disease accesses breakthrough medical innovations that extend and enhance life, transforming cardiovascular care through continuous discovery and partnership between clinicians and technology.
Our mission is to make a meaningful difference in the lives of patients and their families, every day.